Terms: = Liver cancer AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Prognosis
145 results:
1. Deciphering the Mechanism of Siwu Decoction Inhibiting liver Metastasis by Integrating Network Pharmacology and In Vivo Experimental Validation.
Chu X; Xie F; Hou C; Zhang X; Wang S; Xie H; An C; Li Y; Zhao L; Xue P; Zhu S
Integr Cancer Ther; 2024; 23():15347354241236205. PubMed ID: 38462929
[TBL] [Abstract] [Full Text] [Related]
2. USP21 deubiquitinates and stabilizes HSP90 and ENO1 to promote aerobic glycolysis and proliferation in cholangiocarcinoma.
Xu X; Chen Y; Shao S; Wang J; Shan J; Wang Y; Wang Y; Chang J; Zhou T; Chen R; Liu S; Li C; Li C; Li X
Int J Biol Sci; 2024; 20(4):1492-1508. PubMed ID: 38385089
[TBL] [Abstract] [Full Text] [Related]
3. STAT3 palmitoylation initiates a positive feedback loop that promotes the malignancy of hepatocellular carcinoma cells in mice.
Jiang Y; Xu Y; Zhu C; Xu G; Xu L; Rao Z; Zhou L; Jiang P; Malik S; Fang J; Lin H; Zhang M
Sci Signal; 2023 Dec; 16(814):eadd2282. PubMed ID: 38051779
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia-induced SKA3 promoted cholangiocarcinoma progression and chemoresistance by enhancing fatty acid synthesis via the regulation of PAR-dependent HIF-1a deubiquitylation.
Chen Y; Xu X; Wang Y; Zhang Y; Zhou T; Jiang W; Wang Z; Chang J; Liu S; Chen R; Shan J; Wang J; Wang Y; Li C; Li X
J Exp Clin Cancer Res; 2023 Oct; 42(1):265. PubMed ID: 37821935
[TBL] [Abstract] [Full Text] [Related]
5. Association of hypoxia-inducible factor 1α expression with susceptibility to hepatitis B virus-related hepatocellular carcinoma: A meta-analysis.
Wang L; Peng JL
Int J Biol Markers; 2023 Dec; 38(3-4):149-158. PubMed ID: 37787154
[TBL] [Abstract] [Full Text] [Related]
6. HIF-1α and VEGF as prognostic biomarkers in hepatocellular carcinoma patients treated with transarterial chemoembolization.
Pinto E; Pelizzaro F; Cardin R; Battistel M; Palano G; Bertellini F; Kitenge MP; Peserico G; Farinati F; Russo FP
Dig Liver Dis; 2024 May; 56(5):872-879. PubMed ID: 37783655
[TBL] [Abstract] [Full Text] [Related]
7. Exosomal miR-30a-5p promoted intrahepatic cholangiocarcinoma progression by increasing angiogenesis and vascular permeability in PDCD10 dependent manner.
Jiang W; Shi X; Sun L; Zhang Y; Kong X; Yang X; Yin Y; Li C; Li X
Int J Biol Sci; 2023; 19(14):4571-4587. PubMed ID: 37781039
[TBL] [Abstract] [Full Text] [Related]
8. CHSY1 promotes CD8
Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
[TBL] [Abstract] [Full Text] [Related]
9. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
[TBL] [Abstract] [Full Text] [Related]
10. Identification of ferroptosis and drug resistance related hub genes to predict the prognosis in Hepatocellular Carcinoma.
Li C; Cui X; Li Y; Guo D; He S
Sci Rep; 2023 May; 13(1):8681. PubMed ID: 37248280
[TBL] [Abstract] [Full Text] [Related]
11. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis.
Sun W; Lei X; Lu Q; Wu Q; Ma Q; Huang D; Zhang Y
Pathol Res Pract; 2023 Mar; 243():154377. PubMed ID: 36827886
[TBL] [Abstract] [Full Text] [Related]
12. Targeting
Zhao Q; Zhang L; He Q; Chang H; Wang Z; Cao H; Zhou Y; Pan R; Chen Y
J Zhejiang Univ Sci B; 2023 Jan; 24(1):50-63. PubMed ID: 36632750
[TBL] [Abstract] [Full Text] [Related]
13. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles carrying miR-655-3p inhibit the development of esophageal cancer by regulating the expression of HIF-1α via a LMO4/HDAC2-dependent mechanism.
Chen M; Xia Z; Deng J
Cell Biol Toxicol; 2023 Aug; 39(4):1319-1339. PubMed ID: 36222945
[TBL] [Abstract] [Full Text] [Related]
14. Activation of Piezo1 contributes to matrix stiffness-induced angiogenesis in hepatocellular carcinoma.
Li M; Zhang X; Wang M; Wang Y; Qian J; Xing X; Wang Z; You Y; Guo K; Chen J; Gao D; Zhao Y; Zhang L; Chen R; Cui J; Ren Z
Cancer Commun (Lond); 2022 Nov; 42(11):1162-1184. PubMed ID: 36181398
[TBL] [Abstract] [Full Text] [Related]
15. Dysregulation of EZH2/miR-138-5p Axis Contributes to Radiosensitivity in Hepatocellular Carcinoma Cell by Downregulating Hypoxia-Inducible Factor 1 Alpha (HIF-1
Bai B; Liu Y; Fu XM; Qin HY; Li GK; Wang HC; Sun SL
Oxid Med Cell Longev; 2022; 2022():7608712. PubMed ID: 36071871
[TBL] [Abstract] [Full Text] [Related]
16. Vessels that encapsulate tumor clusters (VETC) pattern predicts the efficacy of adjuvant TACE in hepatocellular carcinoma.
Wang JH; Li XS; Tang HS; Fang RY; Song JJ; Feng YL; Guan TP; Ruan Q; Wang J; Cui SZ
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4163-4172. PubMed ID: 36050540
[TBL] [Abstract] [Full Text] [Related]
17. Silencing of OGDHL promotes liver cancer metastasis by enhancing hypoxia inducible factor 1 α protein stability.
Dai W; Li Y; Sun W; Ji M; Bao R; Chen J; Xu S; Dai Y; Chen Y; Liu W; Ge C; Sun W; Mo W; Guo C; Xu X
Cancer Sci; 2023 Apr; 114(4):1309-1323. PubMed ID: 36000493
[TBL] [Abstract] [Full Text] [Related]
18. HNRNPC downregulation inhibits IL-6/STAT3-mediated HCC metastasis by decreasing hif1a expression.
Liu D; Luo X; Xie M; Zhang T; Chen X; Zhang B; Sun M; Wang Y; Feng Y; Ji X; Li Y; Liu B; Huang W; Xia L
Cancer Sci; 2022 Oct; 113(10):3347-3361. PubMed ID: 35848884
[TBL] [Abstract] [Full Text] [Related]
19. Combined HIF-1α and SHH Up-Regulation Is a Potential Biomarker to Predict Poor prognosis in Postoperative Hepatocellular Carcinoma.
Zhao J; Zeng G; Lin E; Cai C; Li P; Zou B; Li J
J Invest Surg; 2022 Aug; 35(8):1660-1667. PubMed ID: 35768071
[TBL] [Abstract] [Full Text] [Related]
20. Engineered Red Blood Cell Membrane-Coating Salidroside/Indocyanine Green Nanovesicles for High-Efficiency Hypoxic Targeting Phototherapy of Triple-Negative Breast cancer.
Pan Y; He Y; Zhao X; Pan Y; Meng X; Lv Z; Hu Z; Mou X; Cai Y
Adv Healthc Mater; 2022 Sep; 11(17):e2200962. PubMed ID: 35735086
[TBL] [Abstract] [Full Text] [Related]
[Next]
